Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.49 is 23% below its 5-year average of 4.55, near the low end of its 5-year range (2.33–11.60).
As of the fiscal period ended Tuesday, June 30, 2026. 7.84% above its 12-month average of 3.23.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.49.
CURRENT RATIO
3.49
CURRENT RATIO AVG TTM
3.23
CURRENT RATIO AVG 3Y
3.38
CURRENT RATIO AVG 5Y
4.55
CURRENT RATIO AVG 10Y
6.73
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+7.84%
CURRENT VS 3Y AVG
+3.06%
CURRENT VS 5Y AVG
-23.38%
CURRENT VS 10Y AVG
-48.21%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.59
median of 798 covered companies
CURRENT VS SECTOR MEDIAN
-2.98%
vs the sector median at left
ProQR Therapeutics N.V.
Market Cap
$173.23M
Current Ratio
3.49
TTM Avg
3.23
3Y Avg
3.38
5Y Avg
4.55
Market Cap
$172.81M
Current Ratio
12.82
TTM Avg
9.83
3Y Avg
6.43
5Y Avg
5.45
Market Cap
$175.39M
Current Ratio
11.22
TTM Avg
14.99
3Y Avg
15.44
5Y Avg
13.43
Market Cap
$170.49M
Current Ratio
3.52
TTM Avg
3.66
3Y Avg
3.27
5Y Avg
3.06
Market Cap
$176.55M
Current Ratio
1.59
TTM Avg
1.58
3Y Avg
1.42
5Y Avg
1.43
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ProQR Therapeutics N.V. (PRQR) | $173.23M | 3.49 | 3.23 | 3.38 | 4.55 |
| Precision BioSciences, Inc. (DTIL)vs › | $172.81M | 12.82 | 9.83 | 6.43 | 5.45 |
| Cue Biopharma, Inc. (CUE)vs › | $172.53M | 1.25 | 2.29 | 3.57 | 4.16 |
| Compass Therapeutics, Inc. (CMPX)vs › | $175.39M | 11.22 | 14.99 | 15.44 | 13.43 |
| Organogenesis Holdings Inc. (ORGO)vs › | $170.49M | 3.52 | 3.66 | 3.27 | 3.06 |
| Journey Medical Corporation (DERM)vs › | $176.55M | 1.59 | 1.58 | 1.42 | 1.43 |
| MediWound Ltd. (MDWD)vs › | $169.76M | 2.32 | 2.15 | 3.17 | 2.88 |
| Nkarta, Inc. (NKTX)vs › | $169.56M | 7.98 | 13.57 | 13.59 | 18.24 |
| Yarrow Bioscience Inc (YARW)vs › | $176.97M | 15.26 | 8.44 | 8.43 | 6.86 |
| OptimizeRx Corp. (OPRX)vs › | $166.07M | 5.58 | 2.96 | 5.18 | 6.05 |
Current Ratio
3.49
Quick Ratio
3.49
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 3.49 |
| 2026-03-31 | 2.48 |
| 2025-12-31 | 3.09 |
| 2025-09-30 | 3.36 |
| 2025-06-30 | 3.76 |
| 2025-03-31 | 4.10 |
| 2024-12-31 | 3.95 |
| 2024-09-30 | 2.33 |
| 2024-06-30 | 2.73 |
| 2024-03-31 | 3.11 |
| 2023-12-31 | 3.54 |
| 2023-09-30 | 4.68 |
| 2023-06-30 | 5.71 |
| 2023-03-31 | 8.25 |
| 2022-12-31 | 7.36 |
| 2022-09-30 | 3.86 |
| 2022-06-30 | 5.93 |
| 2022-03-31 | 7.27 |
| 2021-12-31 | 6.94 |
| 2021-09-30 | 5.10 |
| 2021-06-30 | 11.60 |
| 2021-03-31 | 6.94 |
| 2020-12-31 | 7.77 |
| 2020-09-30 | 8.52 |
| 2020-06-30 | 10.09 |
| 2020-03-31 | 11.04 |
| 2019-12-31 | 10.43 |
| 2019-09-30 | 7.01 |
| 2019-06-30 | 9.51 |
| 2019-03-31 | 10.08 |
| 2018-12-31 | 13.28 |
| 2018-09-30 | 11.39 |
| 2018-06-30 | 4.02 |
| 2018-03-31 | 5.64 |
| 2017-12-31 | 5.95 |
| 2017-09-30 | 6.72 |
| 2017-06-30 | 8.22 |
| 2017-03-31 | 8.38 |
| 2016-12-31 | 9.24 |
| 2016-09-30 | 8.90 |
| 2016-06-30 | 10.36 |
| 2016-03-31 | 14.61 |
| 2015-12-31 | 17.82 |
| 2015-09-30 | 21.33 |
| 2015-06-30 | 21.09 |
| 2015-03-31 | 24.28 |
| 2014-12-31 | 37.79 |
| 2014-09-30 | 43.99 |
| 2014-06-30 | 16.35 |
| 2014-03-31 | 0.00 |
| 2013-12-31 | 1.18 |
| 2013-09-30 | 0.00 |
